J&J Plans €1.75B Offer For Dutch Vaccine Developer
The potential deal, announced Friday, calls for J&J or a subsidiary to purchase all the Crucell shares it does not already own for €24.75 each. The company already owns about 17.9 percent of the Dutch company, valued at about €2.3 billion under the deal.
The negotiations, which...
To view the full article, register now.